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Alcohol intake and cardiovascular 
risk factors: A Mendelian 
randomisation study
Yoonsu Cho1,*, So-Youn Shin2,*, Sungho Won3, Caroline L Relton2,4, George Davey Smith2,† & 
Min-Jeong Shin1,5,†
Mendelian randomisation studies from Asia suggest detrimental influences of alcohol on cardiovascular 
risk factors, but such associations are observed mainly in men. The absence of associations of genetic 
variants (e.g. rs671 in ALDH2) with such risk factors in women – who drank little in these populations 
– provides evidence that the observations are not due to genetic pleiotropy. Here, we present a 
Mendelian randomisation study in a South Korean population (3,365 men and 3,787 women) that 1) 
provides robust evidence that alcohol consumption adversely affects several cardiovascular disease 
risk factors, including blood pressure, waist to hip ratio, fasting blood glucose and triglyceride levels. 
Alcohol also increases HDL cholesterol and lowers LDL cholesterol. Our study also 2) replicates sex 
differences in associations which suggests pleiotropy does not underlie the associations, 3) provides 
further evidence that association is not due to pleiotropy by showing null effects in male non-drinkers, 
and 4) illustrates a way to measure population-level association where alcohol intake is stratified by 
sex. In conclusion, population-level instrumental variable estimation (utilizing interaction of rs671 in 
ALDH2 and sex as an instrument) strengthens causal inference regarding the largely adverse influence 
of alcohol intake on cardiovascular health in an Asian population.
Previous epidemiological studies have reported potential beneficial effects of moderate alcohol intake on cardi-
ovascular health1,2. In a recent review paper combining results from 84 observational studies, moderate drinkers 
were shown to have reduced risks of cardiovascular disease outcomes compared with non-drinkers, although 
heavy drinkers had the highest risks of all3. However, such evidence is not adequate for promotion of moderate 
alcohol use in prevention of heart disease given the known limitations of observational studies2,4. First, observed 
cardio-protective effects may be a form of reverse causation whereby individuals with the early stages of disease 
reduce their alcohol intake2,4,5. Second, observed effects might be due to confounding factors such as socioeconomic 
position, diet or other health-related behaviours and therapeutic regimes4. Therefore, the causal nature of associa-
tion beyond observed correlation must be investigated in order to fully evaluate the benefits or harms of alcohol use.
Potential relationships should be interrogated through methods that can manipulate exposure and observe cor-
responding outcomes while accounting for confounding factors6. The gold standard is a randomised controlled trial 
(RCT), but this may be impossible to implement, prohibitively expensive or unethical. One alternative approach is 
that of Mendelian randomisation7. This method utilises a genetic variant that is allocated at conception in a manner 
that is independent of environment; people with the same genotype are thus akin to randomly allocated group 
of people in an RCT8. In essence, Mendelian randomisation exploits the idea such that a genetic variant, which 
proxies for the exposure, is expected to be related to the outcome to the degree anticipated given its association 
with the exposure. When Mendelian randomisation is implemented as a form of instrumental variable analysis, the 
genetic variant is referred to as an instrumental variable (IV)9. Using a Mendelian randomisation approach, causal 
effects of alcohol intake on cardiovascular outcomes have been investigated in several studies5,10–12. Robust IVs for 
alcohol intake include genetic variants in aldehyde dehydrogenase 2 (ALDH2)13,14 and alcohol dehydrogenase 1B 
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(ADH1B)10. Both these genes are involved in alcohol metabolism (Supplementary Fig. S1), although the ALDH2 
variants have substantially more influence on alcohol intake than the ADH1B variants10. The ALDH2 variants are 
polymorphic mainly in East Asian populations (Supplementary Fig. S2). Individuals who carry the variant allele 
experience on average greater discomfort after drinking alcohol, including nausea and facial flushing (so called 
Asian flush) since the variant allele codes for an inactive form of the enzyme, that leads to build-up of acetaldehyde 
in the circulation following alcohol consumption. As a result, carriage of the ALDH2 variant has consistently been 
linked with drinking behaviours15–19 and alcohol related diseases or risk factors in a number of Asian population 
studies11,15,20–26. For example, these studies consistently suggest that alcohol intake is associated with higher blood 
pressure21,24, not only in heavy drinkers but also in moderate drinkers11, corroborating some observational epi-
demiological studies3. Use of the variant also implies alcohol drinking is associated with coronary artery disease25 
and coronary spastic angina26. On the other hand, some studies suggest alcohol drinking may have a favourable 
influence by increasing high density lipoprotein (HDL) cholesterol or decreasing low density lipoprotein (LDL) 
cholesterol11,22. However, these findings are not always robust10,25 and furthermore, the causal relationship between 
HDL cholesterol and cardiovascular health is uncertain27,28.
For cardiovascular outcomes showing association with the ALDH2 variant, associations have largely been 
confined to Asian men5,21,24. Weak or null associations observed in Asian women are due to a low level of alcohol 
consumption in females irrespective of the genotype, which is analogous to the situation within a RCT framework 
where randomly allocated groups receiving a very low amount of exposure would not result in any difference in 
outcomes21. The difference of associations between men and women provides an excellent rationale that the var-
iant influences outcomes only through the exposure (i.e. alcohol intake), validating an assumption of Mendelian 
randomisation. The reasoning behind this is that if it were not the case – for example, if pleiotropic effects of the 
genetic variant influenced the outcomes - the same association between the variant and outcomes would have 
been seen in women as well as in men, as discussed in detail elsewhere5,20. Nevertheless, this sex stratification 
of alcohol intake also raises a question whether using the rs671 genotype alone as an IV would be sufficient to 
properly assesses causal effects in the whole population when both genetic variants and sex influences on alcohol 
intake should be considered29.
In this study, we carried out a Mendelian randomisation study to investigate the causal effects of alcohol intake 
on a range of cardiovascular outcomes and included the stratification of alcohol intake by gender. Data were col-
lected from a total of 7,152 individuals from South Korea, including 3,365 men and 3,787 women. First, causal 
effects of alcohol intake were investigated in men and women separately, by conventional IV models using the rs671 
genotype in ALDH2 as an IV. To demonstrate that the observed sex differences of association between the variant 
and cardiovascular outcomes were due to difference in corresponding drinking level rather than some particular 
influence of sex, the male-specific association was subsequently evaluated in sub-groups of never-drinkers and 
ever-drinkers. Finally, population-level causal effects were estimated by an extended IV model utilising interaction 
of the rs671 genotype and sex as an IV.
Results
General characteristics. Basic characteristics of male and female participants are shown in Table 1. Mean 
values were different between men and women in most variables with the exception of hip circumference, total 
cholesterol, the rs671 genotype and genotypic principal components. Men were younger, more likely to live in 
urban areas, more educated, doing less exercise and smoking more than women on average. Alcohol intake was 
considerably higher in men than women; 72% of men were current drinkers compared to 26% of women; the 
average alcohol intake was 18.8 ± 0.5 (g/day) in men and 1.3 ± 0.1 (g/day) in women; and gamma- glutamyl 
transpeptidase (GGT) was 55.4 ± 1.6 (IU/L) in men and 19.0 ± 0.3 (IU/L) in women. Men had higher prevalence 
of diseases and more generally unfavourable risk factors than women, although men had a few more generally 
favourable values as well (lower body mass index (BMI) and LDL cholesterol). It should be noted that there was 
no difference between men and women in the prevalence of rs671 genotype and genotypic principal components.
Characteristics were also provided according to the rs671 genotype in each sex group (Table 2). In both men 
and women, the rs671 genotype was in Hardy-Weinberg equilibrium with the A-allele frequency of 16%. The 
rs671 genotype was not associated with lifestyle or socioeconomic factors. Regarding alcohol intake, carriers of 
the rs671 A-allele had a lower proportion of current drinkers and consumed less alcohol than non-carriers in both 
men and women, though the magnitude of difference was bigger in men. With regard to disease prevalence and 
related risk factors, carriers of the rs671 A-allele appeared to have several potentially beneficial effects and a few 
potentially adverse effects than non-carriers (Table 2). All these associations were observed only in men and not in 
women. In addition to lifestyle or disease related factors, potential population stratification of the rs671 genotype 
was investigated through its association against the first five genotypic principal components. The second and the 
fourth principal components were correlated with the rs671 genotype in men (p = 0.02) and women (p = 0.04), 
respectively. Hence, these two principal components were included in the subsequent Mendelian randomisation 
analysis to correct for population stratification.
Next, the male population was divided into two groups by their drinking status: ever-drinkers and 
never-drinkers, and then corresponding characteristics in each group were provided according to the rs671 gen-
otype (Table 3). In this stratified analysis, potential collider bias30 was tested using generalized regression models 
with an interaction of genotype and drinking behaviour. Strong evidence of collider bias was observed for smok-
ing behaviour (interaction p < 0.0001) where its association with genotype by strata were in opposite directions 
(Table 3). To minimize the effect of risk factors susceptible to collider bias, associations between the rs671 genotypes 
and cardiovascular outcomes were then assessed with adjustments for smoking with the results being closely sim-
ilar to those without adjustments. In male ever-drinkers, the rs671 A-allele was associated with several potentially 
beneficial effects and a few potentially adverse effects after adjustments (Table 3). These associations were not 
observed in male never-drinkers, apart from weak associations with waist to hip ratio and fasting glucose level.
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Observational associations. Association results based on the ordinary least squares (OLS) regression 
models can be found in Table 4 and Supplementary Tables S1. In men, alcohol intake was shown to be associated 
with higher hypertension risks, blood pressure, BMI, waist circumference, waist to hip ratio, log-transformed 
fasting blood glucose, HDL cholesterol, log-transformed triglycerides as well as with lower LDL cholesterol. In 
women, alcohol intake was associated with higher hypertension risks, blood pressure, BMI, hip circumference, 
log-transformed fasting glucose, total cholesterol and HDL cholesterol. The heterogeneity of OLS estimates in men 
and women was observed for diastolic blood pressure, log-transformed fasting blood glucose and HDL cholesterol 
and marginally for hypertension, hip circumference and total cholesterol under the fixed effect model. All regres-
sion analysis results were inspected based on plots of the dependent variable against the independent variable as 
well as plots of residuals against fitted values. Neither nonlinear association (such as U shape association) nor a 
structured pattern of residual distribution was evident (data available on request).
All (N = 7,152‡) Men (N = 3,365‡) Women (N = 3,787‡) P-value†
Lifestyle and socio-economic factor*
 Age (yrs) 52.3 ± 0.1 51.9 ± 0.2 52.7 ± 0.1 0.0002
 Area (rural Ansung%/urban Ansan%) 47.2/52.8 43.1/56.9 50.8/49.2 < 0.0001
  Education (elementary school%/middle 
school%/high school%/university%) 33.2/22.9/30.7/13.2 19.7/22.4/36.2/21.6 45.1/23.3/25.9/5.7 < 0.0001
 Physical activity practitioner (%, N) 93.8 (6,609) 91.0 (3,027) 96.2 (3,582) < 0.0001
 Ever smoker (%, N) 40.9 (2,884) 80.5 (2,698) 5.0 (186) < 0.0001
 Current smoker (%, N) 22.2 (1,568) 44.2 (1,482) 2.3 (86) < 0.0001
Alcohol trait
 Ever drinker (%, N) 54.3 (3,849) 82.5 (2,763) 29.1 (1,086) < 0.0001
 Current drinker (%, N) 47.8 (3,387) 72.4 (2,425) 25.7 (962) < 0.0001
 Former drinker (%, N) 6.5 (462) 10.1 (732) 3.3 (124) < 0.0001
 Never drinker (%, N) 45.7 (3,239) 17.5 (586) 71.0 (2,653) < 0.0001
 Alcohol intake (g/day) 9.6 ± 0.3 18.8 ± 0.5 1.3 ± 0.1 < 0.0001
 Alcohol intake in current drinkers (g/day) 20.2 ± 0.5 26.1 ± 0.6 5.2 ± 0.3 < 0.0001
 γ -glutamyl transpeptidase (IU/L) 36.1 ± 0.8 55.4 ± 1.6 19.0 ± 0.3 < 0.0001
Disease
 Hypertension (%, N) 39.4 (2,816) 41.7 (1,404) 37.3 (1,412) < 0.0001
 Cardiovascular disease (%, N) 3.2 (228) 3.9 (130) 2.6 (98) 0.0020
 Coronary heart disease (%, N) 1.7 (122) 2.1 (72) 1.3 (50) 0.008
 Diabetes (%, N) 7.1 (504) 8.3 (278) 6.0 (226) < 0.0001
Cardiovascular risk factor
 Systolic blood pressure (mmHg) 124.9 ± 0.2 125.7 ± 0.3 124.1 ± 0.3 0.0004
 Diastolic blood pressure (mmHg) 81.7 ± 0.1 83.4 ± 0.2 80.2 ± 0.2 < 0.0001
 Body mass index (kg/m2) 24.59 ± 0.04 24.24 ± 0.05 24.90 ± 0.05 < 0.0001
 Waist circumference (cm) 82.7 ± 0.1 83.7 ± 0.1 81.8 ± 0.2 < 0.0001
 Hip circumference (cm) 93.6 ± 0.1 93.6 ± 0.1 93.7 ± 0.1 0.6282
 Waist to hip ratio (continuous) 0.883 ± 0.001 0.894 ± 0.001 0.873 ± 0.001 < 0.0001
 Fasting blood glucose (mg/dL) 87.7 ± 0.3 90.6 ± 0.4 85.0 ± 0.3 < 0.0001
 Total cholesterol (mg/dL) 191.9 ± 0.4 192.0 ± 0.6 191.8 ± 0.6 0.7511
 HDL cholesterol (mg/dL) 44.7 ± 0.1 43.8 ± 0.2 45.5 ± 0.2 < 0.0001
 LDL cholesterol (mg/dL) 115.8 ± 0.4 114.5 ± 0.6 116.9 ± 0.5 0.0021
 Triglycerides (mg/dL) 164.2 ± 1.3 179.9 ± 2.1 150.2 ± 1.5 < 0.0001
Genotype
 rs671 in ALDH2 (GG%/GA%/AA%) 71.0/26.2/2.7 71.2/26.0/2.9 70.9/26.5/2.6 0.7810
Population stratification indicator
 Height (cm) 160.0 ± 0.1 166.9 ± 0.1 153.8 ± 0.1 < 0.0001
 Principal component 1 (continuous) 0.0019 ± 0.0025 −0.0003 ± 0.0037 0.0038 ± 0.0034 0.4200
 Principal component 2 (continuous) 0.0001 ± 0.0024 0.0001 ± 0.0036 0.0001 ± 0.0033 0.9956
 Principal component 3 (continuous) −0.0013 ± 0.0023 − 0.0005 ± 0.0034 − 0.0020 ± 0.0032 0.7419
 Principal component 4 (continuous) − 0.0013 ± 0.0020 − 0.0015 ± 0.0029 − 0.0012 ± 0.0028 0.9382
 Principal component 5 (continuous) − 0.0016 ± 0.0020 − 0.0033 ± 0.0029 − 0.0001 ± 0.0027 0.4252
Table 1.  Characteristics of study participants. *Values are represented as mean ± standard error for 
continuous variables and number of counts and percentage for categorical variables. †P-values are from student’s 
t-test for continuous variables and chi-squared test for categorical variables assessing the difference between 
males and females. ‡Apart from major dependent variables (e.g. hypertension) and major independent variables 
(e.g. alcohol intake), some variables included missing data points.
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Causal estimates from Mendelian randomisation analysis. Causal effects of alcohol intake on cardio-
vascular health and life style factors were inferred by IV estimation techniques (Table 5 and Supplementary Table S2). 
Corresponding causal relationships were also assessed through the association of the rs671 genotype with 
Men (N = 3,365‡) Women (N = 3,787‡)
G/G (N = 2,395) G/A (N = 874) A/A (n = 96) P-value† G/G (N = 2,684) G/A (N = 1,003) A/A (N = 100) P-value†
Lifestyle and socio-economic factor*
 Age (yrs) 51.8 ± 0.2 52.1 ± 0.3 51.6 ± 0.9 0.6015 52.6 ± 0.2 52.6 ± 0.3 53.3 ± 0.8 0.7561
  Area (rural Ansung %/urban 
Ansan%) 43.8/56.2 40.7/59.3 45.8/54.2 0.2430 51.6/48.4 49.2/50.9 45.0/55.0 0.2030
  Education (elementary school %/
middle school %/high school %/
university%) 
20.5/21.9/36.1/21.5 17.7/23.1/37.1/22.1 19.0/29.5/30.5/21.1 0.3860 46.1/23.4/25.0/5.6 42.6/23.4/27.5/6.6 45.5/19.2/33.3/2.0 0.1150
  Physical activity practioner (%, N) 91.6 (2,165) 90.0 (780) 87.2 (82) 0.1540 96.1 (2,538) 96.3 (947) 98.0 (97) 0.5950
 Ever smoker (%, N) 80.7 (1,923) 80.9 (704) 74.0 (71) 0.2520 5.4 (142) 4.2 (41) 3.1 (3) 0.2110
 Current smoker (%, N) 44.6 (1,062) 44.1 (384) 37.5 (36) 0.3940 2.4 (64) 2.0 (20) 2.0 (2) 0.7710
Alcohol trait
 Ever drinker (%, N) 93.0 (2,220) 60.7 (527) 16.8 (16) < 0.0001 35.6 (943) 14.3 (142) 1.0 (1) < 0.0001
 Current drinker (%, N) 82.9 (1,979) 50.4 (437) 9.5 (9) < 0.0001 31.6 (837) 12.5 (124) 1.0 (1) < 0.0001
 Former drinker (%, N) 10.1 (241) 10.4 (90) 7.4 (7) 0.6540 4.0 (106) 1.8 (18) 0 (0) 0.0010
 Never drinker (%, N) 7.0 (166) 39.3 (341) 83.2 (79) < 0.0001 64.4 (1,705) 85.7 (849) 99.0 (99) < 0.0001
 Alcohol intake (g/day) 23.78 ± 0.63 7.28 ± 0.59 0.41 ± 0.20 < 0.0001 1.70 ± 0.13 0.41 ± 0.11 0.02 ± 0.02 < 0.0001
  Alcohol intake in current drinkers 
(g/day) 28.8 ± 0.7 14.6 ± 1.1 4.3 ± 1.7 < 0.0001 5.4 ± 0.4 3.3 ± 0.8 2.3
§ 0.1186
 γ -glutamyl transpeptidase (IU/L) 62.6 ± 2.1 38.6 ± 1.8 26.1 ± 2.0 < 0.0001 19.5 ± 0.4 17.6 ± 0.5 17.6 ± 1.6 0.0095
Disease
 Hypertension (%, N) 43.8 (1,050) 36.8 (322) 33.3 (32) < 0.0001 37.8 (1,014) 36.2 (363) 35.0 (35) 0.6010
 Cardiovascular disease (%, N) 3.6 (87) 4.6 (40) 3.1 (3) 0.4290 2.7 (71) 2.6 (26) 1.0 (1) 0.5960
 Coronary heart disease (%, N) 2.0 (48) 2.6 (23) 1.0 (1) 0.4110 1.2 (33) 1.6 (16) 1.0 (1) 0.6610
 Diabetes (%, N) 8.9 (212) 6.9 (60) 6.3 (6) 0.1460 6.0 (160) 5.9 (59) 7.0 (7) 0.9040
Cardiovascular risk factor
 Systolic blood pressure (mmHg) 126.5 ± 0.4 123.9 ± 0.6 123.2 ± 1.7 0.0003 124.1 ± 0.4 124.3 ± 0.6 123.8 ± 2.0 0.9553
 Diastolic blood pressure (mmHg) 83.9 ± 0.2 82.3 ± 0.4 83.0 ± 1.1 0.0015 80.2 ± 0.2 80.2 ± 0.4 79.7 ± 1.1 0.9151
 Body mass index (kg/m2) 24.3 ± 0.1 24.2 ± 0.1 23.8 ± 0.3 0.1949 24.9 ± 0.1 24.8 ± 0.1 24.9 ± 0.4 0.4150
 Waist circumference (cm) 83.9 ± 0.2 83.2 ± 0.3 82.0 ± 0.7 0.0066 82.0 ± 0.2 81.3 ± 0.3 81.1 ± 1.0 0.1195
 Hip circumference (cm) 93.6 ± 0.1 93.7 ± 0.2 93.0 ± 0.5 0.4840 93.8 ± 0.1 93.5 ± 0.2 93.3 ± 0.6 0.3782
 Waist to hip ratio (continuous) 0.897 ± 0.001 0.888 ± 0.002 0.880 ± 0.005 < 0.0001 0.874 ± 0.002 0.870 ± 0.003 0.869 ± 0.008 0.3304
 Fasting blood glucose (mg/dL) 91.8 ± 0.5 88.3 ± 0.7 83.3 ± 1.3 < 0.0001 84.9 ± 0.3 85.2 ± 0.7 86.7 ± 2.4 0.6904
 Total cholesterol (mg/dL) 191.8 ± 0.8 192.9 ± 1.2 190.5 ± 3.7 0.6971 191.3 ± 0.7 192.9 ± 1.1 192.3 ± 3.7 0.4741
 HDL cholesterol (mg/dL) 44.6 ± 0.2 41.8 ± 0.3 40.3 ± 0.8 < 0.0001 45.6 ± 0.2 45.2 ± 0.3 46.1 ± 1.0 0.3771
 LDL cholesterol (mg/dL) 112.4 ± 0.7 119.4 ± 1.1 120.4 ± 3.4 < 0.0001 116.4 ± 0.6 118.2 ± 1.0 117.2 ± 3.0 0.3131
 Triglycerides (mg/dL) 186.2 ± 2.6 166.0 ± 3.5 151.1 ± 7.9 < 0.0001 149.0 ± 1.7 153.2 ± 3.1 150.6 ± 8.4 0.4184
Population stratification indicator
 Height (cm) 167.0 ± 0.1 166.8 ± 0.2 166.0 ± 0.6 0.2223 153.8 ± 0.1 153.8 ± 0.2 153.2 ± 0.5 0.5572
  Principal component 1 
(continuous) 0.017 ± 0.004 − 0.005 ± 0.007 − 0.006 ± 0.023 0.7174 0.003 ± 0.004 0.002 ± 0.007 0.046 ± 0.020 0.1273
  Principal component 2 
(continuous) − 0.006 ± 0.004 0.015 ± 0.007 0.021 ± 0.020 0.0203 0.002 ± 0.004 − 0.003 ± 0.006 − 0.016 ± 0.023 0.5925
  Principal component 3 
(continuous) − 0.002 ± 0.004 0.004 ± 0.007 − 0.009 ± 0.023 0.6787 − 0.001 ± 0.004 − 0.005 ± 0.007 − 0.006 ± 0.020 0.8225
  Principal component 4 
(continuous) − 0.003 ± 0.003 0.003 ± 0.006 − 0.008 ± 0.017 0.6504 0.0001 ± 0.0033 − 0.0083 ± 0.0054 0.0359 ± 0.0195 0.0389
  Principal component 5 
(continuous) − 0.001 ± 0.003 − 0.007 ± 0.006 − 0.018 ± 0.016 0.5092 0.0003 ± 0.0032 − 0.0018 ± 0.0055 0.0056 ± 0.0166 0.8872
Table 2.  Characteristics of study participants according to their rs671 genotype in ALDH2. *Values 
are represented as mean ± standard error for continuous variables and number of counts and percentage 
for categorical variables. †P-values are from ANOVA test for continuous variables and chi-squared test for 
categorical variables assessing the difference among G/G, G/A and A/A genotype groups. ‡Apart from major 
dependent variables (e.g. hypertension) and major independent variables (e.g. alcohol intake), some variables 
included missing data points. §There is only one current drinker in the female A/A group.
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Ever drinkers in men (N = 2,763††) Never drinkers in men (N = 586††)
Men 
(N = 3,349††)
G/G 
(N = 2,220) G/A (N = 527) A/A (N = 16) P-value†
Adjusted 
P-value‡ G/G (N = 166) G/A (N = 341) A/A (N = 79) P-value†
Adjusted 
P-value‡
Geno-
type*drinking 
behaviour his-
tory interaction 
p-value§
Lifestyle and socio-economic factor*
 Age (yrs) 51.7 ± 0.2 51.5 ± 0.4 51.2 ±  2.3 0.8668 0.548 52.1 ± 0.7 52.9 ± 0.5 51.7 ± 1.0 0.4405 0.974 0.978
  Area (rural 
Ansung%/urban 
Ansan%)
43.9/56.1 40.4/59.6 31.3/68.8 0.2230 0.112 41.6/58.4 40.5/59.5 48.1/51.9 0.4630 0.904 0.475
  Education 
(elementary 
school%/
middle school%/
high school%/
university%) 
20.6/22.0/ 
36.4/20.9
16.9/20.5/ 
37.8/24.7
25.0/25.0/ 
25.0/25.0 0.2840 0.032
19.4/19.4/ 
32.1/29.1
18.6/26.8/ 
36.6/18.0
18.0/29.5/ 
32.1/20.5 0.1070 0.615 0.147
  Physical activity 
practitioner (%, N) 91.5 (2,016) 91.4 (480) 81.3 (13) 0.3440 0.532 92.5 (147) 87.9 (297) 88.3 (68) 0.2970 0.327 0.209
 Ever smoker (%, N) 52.6 (1,167) 51.3 (270) 37.5 (6) 0.4260 — 15.1 (25) 42.4 (144) 43.0 (34) < 0.0001 — < 0.0001
  Current smoker 
(%, N) 46.9 (1,039) 47.9 (252) 31.3 (5) 0.4100 — 13.3 (22) 38.2 (130) 39.2 (31) < 0.0001 — < 0.0001
Alcohol trait
  Alcohol intake (g/day) 25.6 ± 0.7 12.1 ± 0.9 2.4 ± 1.1 < 0.0001 < 0.0001 0 0 0 — — —
 γ -glutamyl 
transpeptidase (IU/L) 65.0 ± 2.2 43.8 ± 2.6 28.3 ± 3.3 < 0.0001 < 0.0001 29.3 ± 2.0 30.8 ± 2.3 25.8 ± 2.4 0.6193 0.194 0.525
Disease
  Hypertension 
(%, N) 44.3 (984) 39.1 (206) 37.5 (6) 0.0830 0.018 36.1 (60) 33.1 (113) 31.7 (25) 0.7270 0.863 0.437
  Cardiovascular 
disease (%, N) 3.6 (80) 4.8 (25) 0 (0) 0.3380 0.412 4.2 (7) 4.4 (15) 3.8 (3) 0.9710 0.735 0.925
  Coronary heart 
disease (%, N) 2.1 (46) 3.0 (16) 0 (0) 0.3350 0.312 1.2 (2) 2.1 (7) 1.3 (1) 0.7470 0.919 0.806
 Diabetes (%, N) 9.0 (199) 6.1 (32) 18.8 (3) 0.0340 0.125 7.8 (13) 7.9 (27) 3.8 (3) 0.4310 0.563 0.363
Cardiovascular risk factor
  Systolic blood 
pressure (mmHg) 126.6 ± 0.4 124.1 ± 0.7 121.5 ± 3.5 0.0091 0.001 124.5 ± 1.3 123.4 ± 0.9 123.3 ± 1.9 0.7471 0.904 0.537
  Diastolic blood 
pressure (mmHg) 84.0 ± 0.2 83.2 ± 0.5 83.3 ± 2.1 0.3322 0.103 82.4 ± 0.9 80.9 ± 0.6 82.7 ± 1.2 0.1825 0.730 0.763
  Body mass index 
(kg/m2) 24.3 ± 0.1 24.4 ± 0.1 24.3 ± 0.8 0.9063 0.796 24.3 ± 0.2 23.9 ± 0.2 23.6 ± 0.3 0.2405 0.269 0.087
  Waist 
circumference (cm) 84.0 ± 0.2 83.8 ± 0.3 83.0 ± 2.1 0.8190 0.527 83.8 ± 0.6 82.3 ± 0.4 81.7 ± 0.8 0.0800 0.064 0.024
  Hip circumference 
(cm) 93.6 ± 0.1 94.1 ± 0.2 95.4 ± 1.3 0.0793 0.045 93.7 ± 0.5 93.1 ± 0.3 92.5 ± 0.6 0.3337 0.347 0.131
  Waist to hip ratio 
(continuous) 0.897 ± 0.001 0.891 ± 0.003 0.869 ± 0.015 0.0156 0.008 0.895 ± 0.005 0.883 ± 0.003 0.881 ± 0.006 0.1013 0.047 0.044
  Fasting blood 
glucose (mg/dL) 91.9 ± 0.6 88.5 ± 0.8 84.9 ± 3.8 0.0081 0.001 91.5 ± 2.5 88.1 ± 1.1 83.1 ± 1.4 0.0267 0.044 0.011
  Total cholesterol 
(mg/dL) 192.0 ± 0.8 194.0 ± 1.6 195.1 ± 11.0 0.5228 0.301 189.2 ± 2.9 191.4 ± 1.9 190.0 ± 4.0 0.7988 0.840 0.751
  HDL cholesterol 
(mg/dL) 44.9 ± 0.2 42.6 ± 0.4 38.6 ± 1.9 < 0.0001 < 0.0001 40.6 ± 0.7 40.4 ± 0.5 40.8 ± 1.0 0.9372 0.628 0.995
  LDL cholesterol 
(mg/dL) 112.1 ± 0.7 119.1 ± 1.5 121.5 ± 9.3 0.0001 < 0.0001 117.7 ± 2.6 120.2 ± 1.7 120.6 ± 3.7 0.6746 0.526 0.455
  Triglycerides (mg/dL) 187.7 ± 2.8 170.9 ± 4.7 178.9 ± 29.2 0.0093 0.003 164.7 ± 9.3 158.8 ± 5.1 145.5 ± 7.5 0.7895 0.410 0.660
Population stratification indicator
 Height (cm) 167.0 ± 0.1 167.1 ± 0.3 168.4 ± 1.4 0.6236 0.576 166.6 ± 0.5 166.4 ± 0.3 165.6 ± 0.6 0.4222 0.146 0.247
  Principal 
component 1 
(continuous)
0.0002 ± 0.0045 − 0.012 ±  0.010 0.053 ± 0.056 0.3130 0.491 0.022 ± 0.016 0.007 ± 0.011 − 0.016 ± 0.026 0.4140 0.198 0.198
  Principal 
component 2 
(continuous)
− 0.006 ± 0.004 0.009 ±  0.009 0.029 ± 0.049 0.2839 0.128 − 0.018 ± 0.017 0.024 ± 0.011 0.015 ± 0.022 0.1008 0.091 0.097
  Principal 
component 3 
(continuous)
− 0.001 ± 0.004 − 0.002 ± 0.008 − 0.055 ± 0.056 0.5542 0.668 − 0.023 ± 0.015 0.014 ± 0.011 0.003 ± 0.026 0.1446 0.223 0.164
Continued
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cardiovascular health and life style factors (Supplementary Tables S3 and S4). In men, alcohol intake, instrumented 
by the rs671 genotype, was associated with higher risks of hypertension, blood pressure, waist circumference, waist 
to hip ratio, log-transformed fasting blood glucose, HDL cholesterol, and log-transformed triglycerides as well as 
with lower LDL cholesterol (all p < 0.05). In women, there was little evidence for causal influences of alcohol intake 
on cardiovascular outcomes with an exception of hip circumference (p = 0.035). The heterogeneity of IV estimates 
in men and women was observed for hip circumference (p = 0.038) under the fixed effect model.
Population-level causal effects were assessed as IV estimates where interaction of the rs671 genotype and sex 
was used as an IV given that alcohol intake was stratified by sex as well in the whole population (Table 6). As a 
result, one unit of alcohol intake (g/day) was associated with higher hypertension risks, blood pressure, waist to 
hip ratio, log-transformed fasting blood glucose, HDL cholesterol, log-transformed triglycerides as well as with 
lower LDL cholesterol at a population level.
Discussion
Here, we present a Mendelian randomisation study on alcohol intake and cardiovascular outcomes by analysing 
7,152 individuals (3,365 men and 3,787 women) in South Korea. Causal influences of the exposure cannot be 
properly measured if the exposure level (alcohol intake, in this study) is indistinguishably low although there is 
a potentially valid IV (the rs671 genotype, in this study). For this reason, potential health outcomes consequent 
on alcohol drinking are not easily assessed in Asian women compared to Asian men5,21. We first replicated null 
or weakly observed association of the rs671 genotype and cardiovascular outcomes in women. Furthermore, we 
ensured such null association in women was not because of any female-specific biological mechanism but because of 
low drinking levels, by demonstrating analogous null association in male never-drinkers. The average alcohol intake 
level was 18.8 g/day in men and 1.3 g/day in women, and 22.9 g/day and 0.0 g/day in male ever- and never-drinkers.
We quantified influences of alcohol intake on a wide range of cardiovascular outcomes by using instrumental 
variable estimation techniques. In men, one unit of alcohol intake (g/day), explained by the rs671 genotype, was 
associated with higher hypertension risks, and higher level of systolic blood pressure, diastolic blood pressure, waist 
circumference, fasting blood glucose, HDL cholesterol, triglycerides, and with lower LDL cholesterol. In women, 
none of these associations were observed as expected due to a very low alcohol intake. In the whole population, 
alcohol intake instrumented by interaction of the rs671 genotype and sex, appeared to have the same effects on 
cardiovascular outcomes as in the male population, although the confidence intervals of the effect sizes were larger.
Overall, we showed that alcohol intake is detrimental to most cardiovascular outcomes in the general Asian 
population as shown previously in Asian male populations11,31. The exception is high HDL cholesterol and low LDL 
cholesterol as they are generally considered favourable risk profiles with respect to cardiovascular health, although 
the protective role of high HDL cholesterol may not be fully established compared to that of low LDL cholesterol 
which has been supported by a number of Mendelian randomisation and RCT studies1,27,28,32.
The credibility of the rs671 genotype in ALDH2 as an IV for alcohol intake has been discussed in many stud-
ies11,12,14,20,21. Biochemically, ALDH2 encodes the main enzyme in alcohol metabolism transferring toxic acetalde-
hyde, into non-toxic acetate. Simultaneously, it prevents another toxic chemical, aldehyde, from accumulating in the 
body. People carrying a mutated allele of this gene that produces an inactive form of the ALDH2 enzyme (which is 
the case mainly in Asians), experience discomfort after drinking such as facial flushing, nausea and a rapid heart-
beat. This is likely to be underlying reason for the association between ALDH2 genotype and drinking behaviour.
In our data, supporting evidence was found that the rs671 genotype in ALDH2 satisfied three core assumptions 
for an IV. First, it was independent of known confounders including age, education, residential area, physical 
activities and smoking status, both in men and women, as expected. Potential residual confounding by population 
Ever drinkers in men (N = 2,763††) Never drinkers in men (N = 586††)
Men 
(N = 3,349††)
G/G 
(N = 2,220) G/A (N = 527) A/A (N = 16) P-value†
Adjusted 
P-value‡ G/G (N = 166) G/A (N = 341) A/A (N = 79) P-value†
Adjusted 
P-value‡
Geno-
type*drinking 
behaviour his-
tory interaction 
p-value§
  Principal 
component 4 
(continuous)
− 0.003 ± 0.004 0.001 ± 0.007 − 0.033 ± 0.041 0.7007 0.855 0.002 ± 0.014 0.005 ± 0.010 − 0.007 ± 0.019 0.8614 0.425 0.806
  Principal 
component 5 
(continuous)
− 0.002 ± 0.004 − 0.004 ± 0.007 0.016 ± 0.029 0.9005 0.998 0.015 ± 0.013 − 0.011 ± 0.009 − 0.025 ± 0.018 0.1605 0.074 0.060
Table 3.  Characteristics of male participants according to drinking behaviour history and the rs671 
genotype in ALDH2. *Values are represented as mean ± standard error for continuous variables and number 
of counts percentage for categorical variables. †P-values are from ANOVA test for continuous variables and 
chi-squared test for categorical variables assessing the difference among G/G, G/A and A/A genotype groups. 
‡Adjusted p-values are from linear regression for continuous variables and logistic regression for categorical 
variables assessing the difference among G/G, G/A and A/A genotype groups, after adjustments for smoking 
behaviour (never/previous/current). §P-values of interaction between genotype and drinking behaviour history 
(never vs. ever drinkers) are from generalized regression models. ††In men with drinking behaviour history 
available, some variables included missing data points apart from major dependent variables (e.g. hypertension) 
and major independent variables (e.g. alcohol intake).
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stratification might exist to some extent, but we adjusted for genotypic principal components as covariates in the 
instrumental variable model. Second, it was strongly associated with alcohol intake (g/day) (F-statistic = 262 in 
men and 38 even in women) confirming that it was an adequate IV unlikely to suffer weak instrument bias in this 
study. Furthermore, the rs671 genotype was also associated with other directly relevant alcohol-related traits. That 
is, people with slow alcohol metabolism due to carriage of a mutated allele (rs671 A-allele) appeared to have lower 
proportion of ever and current drinkers as well as lower levels of GGT. GGT is often used as a biomarker for heavy 
drinking and the lower levels of GGT are likely to be influenced by drinking less alcohol as suggested in the latest 
study33. The third assumption required for instrumental variable analysis (that the ALDH2 genotype influences 
cardiovascular outcomes only through alcohol intake, in this study) is (like the assumption of no unmeasured 
confounding) impossible to validate. However, in this study, null effects in women provided evidence that it was 
unlikely that the estimated causal effects were due to pleiotropic effects; if there were pleiotropic effects, causal 
effects would have been observed in women as well as in men, as argued in detail elsewhere5,21.
Several studies have previously reported the causal relationship between alcohol intake and cardiovascular out-
comes10,11,20–23. One of main strengths of the current study lies in relatively accurate estimation of population-level 
causal effects of alcohol intake when the alcohol intake is stratified by gender. Instead of the genotype alone, we 
formally used interaction of the genotype and sex as an IV for alcohol for the first time to our knowledge. Secondly, 
we considered a broad spectrum of cardiovascular outcomes compared to previously studies in an Asian popula-
tion. For example, Chen et al. reported a sex-specific causal effect of alcohol intake on systolic and diastolic blood 
pressures and hypertension21 in their meta-analysis based on results extracted from published data, whereas we 
estimated both sex-specific and population-level causal effects on 12 additional outcomes in as large as or larger 
samples in individual level data. In another previous study, Kato et al. reported a strong sex-specific association of 
the rs671 genotype and blood pressures22 and also showed that such association was mediated by alcohol intake 
implying a causal relationship between alcohol intake and blood pressures, but their approach was limited in terms 
of quantification of the causal effects compared to the IV analysis that we applied in the current study. Finally it 
should be also mentioned that in a recent paper, Holmes et al. extensively covered the causal relationship of alcohol 
intake with various cardiovascular events and risk factors in the largest samples to date10; however, they used a 
different IV, the rs1229984 genotype in ADH1B which is known to be a much weaker IV than the rs671 genotype 
in ALDH2 we used, as the latter is not polymorphic in European individuals of their study. Therefore, our current 
study is one of the most comprehensive study providing robust causal effects of alcohol intake on cardiovascular 
health outcomes. Another interesting feature of this study may be that it is one of the first Mendelian randomisa-
tion studies quantifying causal effects in alcohol intake in the Korean population, although there exists a relevant 
observational study34. The Korean population was selected, not only because it is an Asian population carrying a 
mutated rs671-A allele in ALDH2, but also because the population level alcohol intake is 71% and 84% higher than 
Japan and China, respectively, ranking it as the country with the highest level of heavy drinking in Asia (based on 
Men (N = 3,365‡) Women (N = 3,787‡) Heterogeneity 
P-value†OR (95% CI) by OLS estimation* P-value OR (95% CI) by OLS estimation* P-value
Disease 
 Hypertension 1.007 (1.005, 1.010) < 0.0001 1.021 (1.008, 1.035) 0.002 0.048
 Cardiovascular disease 0.995 (0.988, 1.003) 0.266 1.008 (0.976, 1.041) 0.618 0.937
 Coronary heart disease 1.001 (0.992, 1.009) 0.868 1.018 (0.989, 1.047) 0.231 0.274
 Diabetes 0.999 (0.994, 1.004) 0.756 1.002 (0.974, 1.030) 0.914 0.843
Beta coefficient (95% CI) by OLS estimation* P-value Beta coefficient (95% CI) by OLS estimation* P-value
Cardiovascular risk factor 
 Systolic blood pressure (mmHg) 0.075 (0.055, 0.095) < 0.0001 0.159 (0.061, 0.258) 0.002 0.099
 Diastolic blood pressure (mmHg) 0.049 (0.035, 0.062) < 0.0001 0.154 (0.091, 0.216) < 0.0001 0.001
 Body mass index (kg/m2) 0.004 (0.001, 0.008) 0.017 0.020 (0.003, 0.038) 0.024 0.104
 Waist circumference (cm) 0.022 (0.012, 0.031) < 0.0001 0.046 (− 0.001, 0.093) 0.054 0.328
 Hip circumference (cm) 0.0057 (− 0.0004, 0.0117) 0.068 0.0388 (0.0072, 0.0704) 0.016 0.043
 Waist to hip ratio (continuous) 0.0002 (0.0001, 0.0002) < 0.0001 0.0002 (− 0.0002, 0.0005) 0.386 0.869
  Log-transformed fasting blood glucose 
(log(mg/dL)) 0.0004 (0.0003, 0.0005) < 0.0001 0.0004 (0.0000, 0.0008) 0.043 < 0.0001
 Total cholesterol (mg/dL) 0.010 (− 0.033, 0.052) 0.659 0.207 (0.017, 0.396) 0.033 0.048
 HDL cholesterol (mg/dL) 0.059 (0.047, 0.071) < 0.0001 0.196 (0.142, 0.251) < 0.0001 < 0.0001
 LDL cholesterol (mg/dL) − 0.130 (− 0.170, − 0.090) < 0.0001 − 0.023 (− 0.191, 0.145) 0.786 0.226
 Log-transformed triglycerides (log(mg/dL)) 0.0010 (0.0008, 0.0013) < 0.0001 0.0005 (− 0.0006, 0.0015) 0.393 0.327
Table 4.  Ordinary least squares estimates of alcohol intake (g/day) to cardiovascular health outcomes. *OR 
and beta coefficients by OLS estimation were obtained from standard regressions with an ordinary least squares 
estimation method (in logistic regression models and in linear regression models, respectively). All regression 
models were adjusted for age, area, education, physical activity and smoking status. †Heterogeneity in estimates 
between males and females was assessed by Cochran’s Q test with fixed effects. ‡Apart from major dependent 
variables (e.g. hypertension) and major independent variables (e.g. alcohol intake), some variables included 
missing data points.
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the alcohol per capita consumption on average between 2008 and 2010 in the 2014 WHO report). Our results were, 
however, consistent with those in other instrumental variable based studies in Japan21 and China11.
Nevertheless, our study has limitations. One of main limitation is the use of imputed genotype ALDH2 rs671 
although the imputed genotype was generated by a standardised protocol. Genotypes were quality controlled prior 
to imputation (based on missing call rates, minor allele frequency, Hardy-Weinberg equilibrium and sex match) 
and publicly available reference datasets were used with commonly used and previously evaluated software35,36. In 
addition, imputed genotypes were evaluated based on imputation quality score and Hardy-Weinberg equilibrium 
test. Thus, our imputed genotype would be as informative as a directly measured genotype, as shown in numerous 
genome-wide association studies. Also we acknowledge the limitation of the stratified analysis, as the stratification 
of the male population on drinking behaviour history (ever vs. never drinkers) could introduce collider bias30. We 
identified a risk factor susceptible to collider bias in our data, and adjusted for its effect on associations between 
genotype and cardiovascular outcomes, which produced little change in the effect estimates.
Despite providing evidence for a causal link between alcohol intake and a range of cardiovascular traits, our 
study did not observe clear causal effects of alcohol intake on cardiovascular disease or body mass index. This is 
consistent with previous evidence, such as that provided by Au Yeung et al. who reported a null effect of alcohol 
intake on cardiovascular disease in Chinese men11, although a recent meta-analysis by Holmes et al.10 reported 
strong effects on both in individuals of European descent. One possible explanation is that our study and the study 
by Au Yeung et al.11 were underpowered to detect the causal effect as the samples sizes were much smaller than 
those accrued by Holmes et al. (7,152, and 4,500 compared with 260,000, respectively)10. However, it is not straight-
forward to draw such conclusion yet because these studies have not only different sample sizes, but also different 
instruments (ALDH2 genotype being a stronger instrument than ADH1B genotype), different ethnic backgrounds 
(Korean and Chinese compared with European) and different methods were used to define cardiovascular disease 
(self- report and self- report compared with combination of self- report, medical records, clinical/lab measures, 
death certificate and ICD code). Thus, a carefully designed large-scale study in well-phenotyped Asian population 
would be needed to further investigate this discrepancy.
In conclusion, this study indicates that a reduction in alcohol intake may be beneficial to cardiovascular health 
through avoiding detrimental influences on cardiovascular risk factors.
Methods
Study participants. Subjects for the analysis were obtained from two population based studies within 
the Korean Genome and Epidemiology Study (KoGES), the rural Ansung and urban Ansan cohorts. Detailed 
information for each study has been described elsewhere37. Briefly, the Ansung-Ansan cohorts were designed as 
Men(N = 3,365‡) Women(N = 3,787‡) Heterogeneity 
P-value†OR (95% CI) by IV estimation* P-value OR (95% CI) by IV estimation* P-value
Disease
 Hypertension 1.020 (1.010, 1.029) < 0.0001 1.042 (0.921, 1.178) 0.516 0.736
 Cardiovascular disease 0.990 (0.968, 1.013) 0.390 1.206 (0.827, 1.759) 0.331 0.397
 Coronary heart disease 0.994 (0.965, 1.024) 0.705 0.996 (0.614, 1.616) 0.988 0.994
 Diabetes 1.018 (1.000, 1.036) 0.053 0.968 (0.768, 1.220) 0.783 0.662
Beta coefficient (95% CI) by IV 
estimation* P-value
Beta coefficient (95% CI) by IV 
estimation* P-value
Cardiovascular risk factor
 Systolic blood pressure (mmHg) 0.159 (0.085, 0.234) < 0.0001 − 0.352 (− 1.292, 0.589) 0.464 0.289
 Diastolic blood pressure (mmHg) 0.085 (0.035, 0.135) 0.001 − 0.109 (− 0.701, 0.483) 0.718 0.522
 Body mass index (kg/m2) 0.012 (− 0.001, 0.025) 0.061 0.098 (− 0.079, 0.274) 0.277 0.340
 Waist circumference (cm) 0.060 (0.026, 0.094) 0.001 0.425 (− 0.058, 0.909) 0.085 0.140
 Hip circumference (cm) 0.005 (− 0.017, 0.028) 0.633 0.358 (0.025, 0.690) 0.035 0.038
 Waist to hip ratio (continuous) 0.0006 (0.0004, 0.0008) < 0.0001 0.0012 (− 0.0023, 0.0047) 0.501 0.739
 Log− transformed fasting blood glucose (log(mg/dL)) 0.0010 (0.0006, 0.0014) < 0.0001 − 0.0014 (− 0.0052, 0.0025) 0.494 0.253
 Total cholesterol (mg/dL) − 0.040 (− 0.196, 0.116) 0.614 − 0.897 (− 2.817, 1.023) 0.360 0.383
 HDL cholesterol (mg/dL) 0.170 (0.124, 0.216) < 0.0001 0.266 (− 0.278, 0.810) 0.338 0.731
 LDL cholesterol (mg/dL) − 0.405 (− 0.552, − 0.258) < 0.0001 − 1.007 (− 2.702, 0.688) 0.244 0.488
 Log− transformed triglycerides (log(mg/dL)) 0.002 (0.001, 0.003) < 0.0001 − 0.007 (− 0.018, 0.004) 0.222 0.139
Table 5.  Instrumental variable estimates of alcohol intake (g/day) to cardiovascular health outcomes, 
based on the rs671 genotype in ALDH2. *OR and beta coefficient by IV estimation were obtained from 
instrumental variable regressions with a two stage least squares estimation method (in logistic regression 
models and in linear regression models, respectively), using rs671 genotype as an instrument for alcohol 
intake. All regression models were adjusted for age, area, education, physical activity and smoking status. 
†Heterogeneity in estimates between males and females was assessed by Cochran’s Q test with fixed effects. 
‡Apart from major dependent variables (e.g. hypertension) and major independent variables (e.g. alcohol 
intake), some variables included missing data points.
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longitudinal prospective studies initiated in 2001 and adopted the same investigational method. Participants in 
each cohort (5,018 in Ansung and 5,020 in Ansan aged 39–70) were recruited using a two-stage cluster sampling 
method. All participants took part in a health examination, interviews, and laboratory tests. The current study 
was based on the baseline data collected in 2001 from a total of 7,152 participants having the rs671 genotype in 
ALDH2 available. All participants provided informed consent which was approved by the Human Subjects Review 
Committee at the Korea University Ansan Hospital or the Ajou University Medical Centre. The current study was 
approved by the Institute Review Board at the Korea University (KU-IRB-14-EX-153-A-1).
Basic characteristics. Information was collected on demographic characteristics including age, area, educa-
tion, physical activity and current smoking status. Education level was divided into four groups: elementary school, 
middle school, high school, or university. Physical activity was divided into two groups: practice or do not practice, 
according to whether or not the individual participated in any of the following daily activity types; intense physical 
activity at least 20 minutes, moderate physical activity at least 30 minutes, or walking at least 30 minutes. Current 
smokers were defined as a person who smoked cigarettes regularly at the time of the survey.
Alcohol traits. Participants were also asked about their lifetime drinking behaviour, current drinking behav-
iour and detailed drinking behaviour over the previous 30 days, including frequency, amount and type of alcoholic 
beverages. Using this information along with average alcohol content of each beverage, total alcohol intake (g/day) 
was calculated. Further information on alcohol intake can be found in a previous publication38. As well as total 
alcohol intake (g/day), current drinking status, alcohol intake in current drinkers and GGT were considered as 
alcohol-related traits in this study. A current drinker was defined as an individual who drank alcoholic beverages 
regularly at the time of the survey. GGT concentration (IU/L) was measured from blood samples in the Seoul 
Clinical Laboratories (Seoul, Republic of Korea) collected after at least 8 hours of fasting.
Blood pressure and other risk factors. Blood pressure was measured in a sitting position with a mer-
cury sphygmomanometers after at least 5 minutes of rest. Two acceptable measurements of blood pressure were 
obtained within a 1 minute interval and recorded to the nearest 2 mmHg. Average measurements for systolic and 
diastolic blood pressure were used for statistical analysis. Height (cm) and body weight (kg) were measured to 
the nearest 0.1 cm or 0.1 kg without shoes, from which BMI (kg/m2) was derived. Waist circumference (cm) was 
measured at the narrowest part between the lower rib and the iliac crest to the nearest 0.1 cm, and the average of 
3 repeated measurements was calculated. Hip circumference was measured at the widest portion of the buttocks 
to the nearest 0.1 cm, and the average of 3 repeated measurements was calculated. Waist to hip ratio was derived 
from waist circumference and hip circumference.
All (N = 7,152†)
OR (95% CI) by IV estimation* P-value
Disease
 Hypertension 1.031 (1.001, 1.062) 0.040
 Cardiovascular disease 0.949 (0.988, 1.004) 0.362
 Coronary heart disease 0.984 (0.886, 1.093) 0.762
 Diabetes 1.045 (0.989, 1.104) 0.117
Beta coefficient (95% CI) by IV 
estimation* P-value
Cardiovascular risk factor
 Systolic blood pressure (mmHg) 0.202 (0.087, 0.317) 0.001
 Diastolic blood pressure (mmHg) 0.100 (0.025, 0.175) 0.009
 Body mass index (kg/m2) 0.004 (− 0.017, 0.024) 0.732
 Waist circumference (cm) 0.023 (− 0.032, 0.078) 0.410
 Hip circumference (cm) − 0.025 (− 0.061, 0.011) 0.179
 Waist to hip ratio (continuous) 0.0005 (0.0001, 0.0009) 0.013
 Log-transformed fasting blood glucose (log(mg/dL)) 0.0012 (0.0006, 0.0017) < 0.0001
 Total cholesterol (mg/dL) 0.038 (− 0.197, 0.273) 0.750
 HDL cholesterol (mg/dL) 0.166 (0.098, 0.233) < 0.0001
 LDL cholesterol (mg/dL) − 0.362 (− 0.578, − 0.145) 0.001
 Log-transformed triglycerides (log(mg/dL)) 0.003 (0.002, 0.005) < 0.0001
Table 6.  Instrumental variable estimates of alcohol intake (g/day) to cardiovascular disease and risk 
factors, based on interaction of the rs671 genotype in ALDH2 and sex. *OR and beta coefficients by IV 
estimation were obtained from instrumental variable regressions with a two stage least squares estimation 
method (in logistic regression models and in linear regression models, respectively), using interaction of 
rs671 genotype and sex as an instrument for alcohol intake. All regression models were adjusted for age, area, 
education, physical activity and smoking status. †Heterogeneity in estimates between males and females was 
assessed by Cochran’s Q test with fixed effects. ‡Apart from major dependent variables (e.g. hypertension) and 
major independent variables (e.g. alcohol intake), some variables included missing data points.
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For laboratory tests, all participants had at least an 8 hour fasting period before blood collection. Collected 
blood samples were analysed in the Seoul Clinical Laboratories (Seoul, Republic of Korea) for assays including 
fasting blood glucose (mg/dL), total cholesterol (mg/dL), HDL cholesterol (mg/dL), and triglycerides (mg/dL). 
LDL cholesterol (mg/dL) was derived using the Friedewald formula39 in subjects with triglycerides less than 
400 mg/dL as follows; LDL cholesterol = total cholesterol– HDL cholesterol– (triglycerides/5.0). For subjects with 
triglycerides of 400 mg/dL or more, LDL cholesterol value was marked as missing. GGT concentration (IU/L) was 
measured from the same blood samples.
Disease outcome. According to health interview and examination, participants with self-reported diagnosed 
hypertension, use of blood pressure medicine, or measured systolic blood pressure greater than 140 mmHg, or 
diastolic blood pressure greater than 90 mmHg were considered as hypertensive. Cardiovascular disease status was 
defined by doctor-diagnosed and self-reported questionnaire information on myocardial infarction, congestive 
heart failure, coronary artery disease, peripheral blood vessel disease, and cerebrovascular disease. A coronary heart 
disease event was additionally defined by the same questionnaire information but only on myocardial infarction and 
coronary artery disease. Diabetes was defined by doctor-diagnosed and self-reported questionnaire information.
Genotyping quality control and imputation. Detailed information is provided elsewhere37. Briefly, DNA 
samples were isolated from the peripheral blood of participants and genotyped using the Affymetrix Genome-Wide 
Human SNP array 5.0 (Affymetrix, Inc., Santa Clara, CA, USA). The accuracy of the genotyping was calculated by 
Bayesian Robust Linear Modelling using the Mahalnobis Distance genotyping algorithm40. A total of 352,228 SNPs 
in 8,842 participants became available after pre-imputation QC, 1) excluding SNPs with high missing genotype 
call rates (> 5%), with minor allele frequency (MAF) < 0.01, and not in Hardy-Weinberg equilibrium (HWE, P 
value < 1 × 10−6) and 2) removing samples with sex mismatch. Genetic principal components were computed in a 
subset of 304,225 SNPs after excluding additional 48,003 SNPs (not in HWE under a more conservative criterion, 
P value < 1 × 10−5) through the EIGENSTRAT software package41.
To impute rs671 ALDH2 genotype (http://www.ncbi.nlm.nih.gov/projects/SNP/), all genotypes in chromosome 
12 were imputed using the 1000 Genomes Phase 1 v3 reference panel. The reference datasets of all populations 
were downloaded from the IMPUTE2 website35. To minimise the computational intensity and increase efficiency, 
genotypes were pre-phased with SHAPEIT36 prior to imputation by IMPUTE235 with the default options. As a 
post-imputation QC, SNPs were removed if MAF was low (< 0.05) or the imputation info value was low (< 0.8). 
As a result, the rs671 genotype in ALDH2 became available in a total of 7,152 participants with expected MAF of 
0.194 and imputation info value of 0.845.
Statistical analysis. Statistical analyses were performed using Stata SE 12.0 (Stata Corp, Carollina, USA). 
First, the distribution of variable values was investigated. Fasting blood glucose, GGT and triglycerides were 
log-transformed to mimic a Gaussian distribution. No outliers were detected by visual inspection. Descriptive 
statistics of all variable values were presented as mean ± standard error for a continuous variable, and as number 
of counts and percentage for a categorical variable in men and women separately, according to their rs671 gen-
otype in ALDH2. Apart from major dependent variables (e.g. hypertension) and major independent variables 
(e.g. alcohol intake), some variables included missing data points. Mean difference of these variables in men and 
women was evaluated through Student’s t-test for a continuous variable and by chi-squared test for a categorical 
variable. Similarly, mean differences in these variables among three different rs671 genotype groups were compared 
using one-way analysis of variance (ANOVA) for a continuous variable and using chi-squared test for a categor-
ical variable; in men and women, and in male ever-drinkers and male never-drinkers, separately. In addition, in 
order to evaluate potential collider stratification bias, the difference of variable distribution by genotype between 
male ever-drinkers and male never-drinkers was tested using generalized regression models which include rs671 
genotype, drinking behaviour history (never vs. ever) and interaction of genotype and drinking behaviour history 
as the independent variables.
The association between alcohol intake and other variables was assessed under an OLS regression model in 
men and women, separately. Continuous risk factors were predicted by alcohol intake under a linear regression 
model adjusting for potential confounding factors such as age, area, education, physical activity and smoking status. 
Hypertension, cardiovascular disease, coronary heart disease and diabetes were also predicted by alcohol intake 
under a logistic regression model adjusting for the same potential confounding factors. In order to investigate the 
potential violation of assumptions such as linearity of association and normality of the error distribution, plots of 
dependent variables against independent variables as well as plots of residuals against fitted values were generated. 
Results are presented as estimated regression coefficients β with 95% confidence interval (CI) for a continuous 
variable, and estimated odds ratio (OR) with 95% CI for a categorical variable. Corresponding p-values are also 
provided. The difference of estimates between men and women was assessed by Cochran’s Q test using fixed effect 
models assuming the true effect of alcohol is the same in men and women.
Lastly, the causal effect of alcohol intake on other variables was measured under an IV regression with a two 
stage least squares estimation method in men and women, separately, using the rs671 genotype as an instrument. 
For continuous risk factors, a two stage linear model was performed, with adjustments for age, area, education, 
physical activity and smoking status as well as additional adjustments for genotypic principal components to take 
into account population structure for the rs671 genotype. For hypertension and cardiovascular disease, a two stage 
logistic model was conducted; in the first stage, alcohol intake was predicted by rs671 genotype (with additive 
effect) under a linear regression model (adjusted for age, area, education, physical activity, smoking status and 
principal components); in the second stage, disease outcome was predicted by fitting the alcohol intake value from 
the first stage, under a logistic regression model (adjusted for the same potential confounding factors). Results 
were shown by providing estimated regression coefficients β with 95% CI for a continuous variable, and estimated 
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OR, with 95% CI for a categorical variable along with corresponding p-values. The difference of estimates between 
men and women was assessed by Cochran’s Q test using fixed effect models assuming the true effect of alcohol is 
the same in men and women.
The same causal effect was then quantified in the whole population, using interaction of the rs671 genotype and 
sex as an instrument. Instrumental variable regression models were additionally adjusted for the rs671 genotype 
and sex, the variables that were used to compute the interaction. It should be noted that interaction of the rs671 
genotype and sex was used as an instrument even if the rs671 genotype was directly included in the model42.
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